Desk›Healthcare› Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd
BSE 543308 · NSE KIMS · ISIN INE967H01025 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹769.80
-0.01%
BSE close, 28 August 2026
₹32,332.10 cr
42.0 cr shares · Mid cap
₹20,488.46 cr
as published
120.5× · 16.18×
EPS ₹6.39 · BV ₹47.58
1,701.50 / 260.70
₹ cr, as filed
32
9 selected · 28%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -10.3% |
|---|---|
| Against 52-week low | +33.8% |
| Day change | -0.01% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹6.39 |
|---|---|
| Price / earnings | 120.47× |
| Price / book | 16.18× |
| Book value — derived, price ÷ P/B | ₹47.58 |
| Return on equity | 13.43% |
| Operating margin | 30.79% |
| Net margin | 13.75% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 13.43%
- ROE as published
- 13.43%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 483.60 | 66.50 | 1.66 | 30.79% | 13.75% |
| Mar-26 · Q | 456.20 | 65.90 | 1.65 | 31.00% | 14.45% |
| FY25-26 | 1,701.50 | 260.70 | 6.52 | 30.41% | 15.32% |
Quarter on quarter
- Revenue, quarter on quarter
- +6.0%
- Net profit, quarter on quarter
- +0.9%
- Operating margin, quarter on quarter
- -21 bps
Disclosure profile 32 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Acquisition | 4 |
| Board Outcome | 1 |
| Contract / MoU | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| Analyst / Investor Meet | 6 |
| General | 6 |
| AGM / EGM | 2 |
| Newspaper Publication | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| SAST | 1 |
| Procedural sub-total | 23 |
| Total | 32 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
32 filings · 9 selected · busiest 2026-08-03
Filing rhythm · the twelve most recent
2026-08-272026-10-08
SelectedProcedural
Filings
32 in the window · 13 earlier on record
-
8 October 2026 ·
-
7 October 2026 ·
General Update To Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
General Update
Company Update / General View filing →
-
6 October 2026 ·
-
6 October 2026 ·
-
6 October 2026 ·
-
6 October 2026 ·
Acquisition
Intimation u/r 30-acquistion of upto 51 % stake in Insignia
Company Update / Acquisition View filing →
-
23 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
15 September 2026 ·
Analyst / Investor Meet - Intimation
Anand Rathi Annual Flagship Conference G-200 Summit 2026
Company Update / Analyst / Investor Meet View filing →
-
15 September 2026 ·
Analyst / Investor Meet - Intimation
J.P. Morgan India Conference
Company Update / Analyst / Investor Meet View filing →
-
10 September 2026 ·
Memorandum of Understanding /Agreements
The Company has entered into Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh.
Company Update / Memorandum of Understanding /Agreements View filing →
-
7 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of schedule of Analyst / Institutional Investor Meeting.
Company Update / Analyst / Investor Meet View filing →
-
27 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 24th Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Clarification Regarding Article Appearing In Dealstreetasia.Com Dated 25Th August 2026 Titled 'Chryscapital- Backed KIMS In Talks To Acquire Stake In Renova Hospitals For $52 Million
Clarification regarding article appearing in Dealstreetasia.com
Company Update / General View filing →
-
20 August 2026 ·
KIMS Has Entered Into An Operations And Management Agreement And Call Option Agreement With Aurevia Hospitals Private Limited (Formerly Known As Golden Lan Solution Private Limited), Hyderabad, Telangana
KIMS has entered into Operations and Management agreement with Aurevia Hospitals Private Limited
Company Update / General View filing →
-
20 August 2026 ·
-
7 August 2026 ·
Intimation Of Receipt Of The In-Principle Approval From BSE Limited And The National Stock Exchange Of India Limited
Intimation of receipt of the In-Principal Approval for the issue and allotment of warrants to promoters/promoters group on a preferential basis
Company Update / General View filing →
-
6 August 2026 ·
Newspaper Publication
Copy of Newspaper Publication towards intimation of notice of 24th Annual General Meeting of the Company.
Company Update / Newspaper Publication View filing →
-
5 August 2026 ·
Letter To Shareholders Regarding Annual Report
Letter to Shareholders Regarding Annual Report
Company Update / General View filing →
-
5 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR for the FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
5 August 2026 ·
Reg. 34 (1) Annual Report.
24th Annual Report for the FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
5 August 2026 ·
24Th Annual General Meeting Of The Company Scheduled To Be Held On 27Th August 2026
24th Annual General Meeting Scheduled to be held on 27th August, 2026
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Intimation
Emkay Confluence 2026
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Newspaper Publication
Newspaper Publication on the unaudited financial results for 01st quarter ended 30th June, 2026.
Company Update / Newspaper Publication View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Conference Call with Investors/ Analysts for Q1 FY27.
Company Update / Analyst / Investor Meet View filing →
-
3 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the Quarter ended June 30, 2026.
Company Update / Monitoring Agency Report View filing →
-
3 August 2026 ·
Statement Of Deviation
Statement of Deviation for quarter ended June 30, 2026.
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
3 August 2026 ·
Press Release / Media Release
Press Release for Q1FY27
Company Update / Press Release / Media Release View filing →
-
3 August 2026 ·
-
3 August 2026 ·
Financial Results For Q1 2026-27
Financial Results for Q1 2026-27
Result / Financial Results View filing →
-
3 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On 03Rd August, 2026
Outcome of the Board meeting held on 03rd August 2026
Board Meeting / Outcome of Board Meeting View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation about a conference call for analysts and investors
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Board Meeting Intimation for Board Meeting Intimation
Krishna Institute Of Medical Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve We hereby ....
Board Meeting / Board Meeting View filing →
RSS feed for Krishna Institute of Medical Sciences Ltd · the 50 most recent filings